Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQZBC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,332
Award facts
- Contract value 100% obligated
- $3,332.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $3,332.47. This non-set-aside contract utilizes firm fixed price pricing and requires completion by July 22, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.9 million and running through December 2026. Performance will be conducted at the contractor's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The contractor's extensive federal contract portfolio demonstrates its capability to deliver a broad range of pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies. This delivery order is part of the DLA's Medical Supply Chain operations, which leverage AmerisourceBergen's global distribution network to support Defense Health Agency initiatives and other federal healthcare systems. The DLA is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a key supplier within this strategic procurement framework.
Quick answers
Who was awarded contract SPE2DB25FQZBC?
SPE2DB25FQZBC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FQZBC worth?
The government has obligated $3,332 on SPE2DB25FQZBC.
Is contract SPE2DB25FQZBC an order under another contract?
Yes. SPE2DB25FQZBC is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZBC competed?
The extent of competition for SPE2DB25FQZBC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award